Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Clinical Trial ID NCT01815749

PubWeight™ 13.24^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01815749

Top papers